Reinventing for returns: what's next in pharma?

PwC's Next in Health
13/03/2024 13 min Temporada 5 Episodio 1
Reinventing for returns: what's next in pharma?

Listen "Reinventing for returns: what's next in pharma?"

Descargar episodio

Episode Synopsis

Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry. Key topics include:The headwinds for pharma are real and sustained Rethinking the innovation strategy Accelerate using AI and analytics Lower costs M&A as a catalyst for transformation Protecting the enterpriseSpeakers:Jenny Colapietro, Health Industries Vice Chair, PwC Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwCGreg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwCFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

More episodes of the podcast PwC's Next in Health

Deals Outlook 2026: What’s ahead for medtech 07/01/2026
Deals Outlook 2026: What’s ahead for health services 19/12/2025
Deals Outlook 2026: What’s ahead for pharma and life sciences 19/12/2025
Reinventing Healthcare - Seizing the $1 Trillion Breakthrough 21/10/2025
The One Big Beautiful Bill: What It Means for the Future of U.S. Healthcare 01/08/2025
Strategic Dealmaking in Health: Navigating Midyear Trends in 2025 10/07/2025
Taking a closer look at the Most Favored Nation Pricing Executive Order 03/06/2025
Navigating the FDA disruption: 4 key actions for pharma 23/05/2025
Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma 22/05/2025
Navigating Healthcare’s Next Chapter Under the Trump Administration 23/04/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA